Aurobindo Pharma Schedules Investor and Analyst Group Meeting in Hyderabad
Aurobindo Pharma Ltd 路 Intimation 路 11 Sept 2026, 10:00 pm
Aurobindo Pharma Schedules Investor and Analyst Group Meeting in Hyderabad Aurobindo Pharma Limited announced that company officials will participate in an investor and analyst group meeting arranged by Emkay Global. The in-person meeting is scheduled to take place in Hyderabad on 17th Sep'26 from 10:00 AM to 11:00 AM IST. The company confirmed that no unpublished price sensitive information (UPSI) will be discussed during the interaction, and the schedule remains subject to changes depending on exigencies from either party.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. 路 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. 路 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". 路 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. 路 09 Nov 2026
- Intimation of investor / analysts meet to be held on 16.09.2026. 路 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. 路 05 Nov 2026
- Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company. 路 05 Nov 2026
